Pinnacle Wealth Planning Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Pinnacle Wealth Planning Services's BIIB Position: Q2 2026 in Review
Pinnacle Wealth Planning Services increased its Biogen (BIIB) stake by 0.29% in Q2 2026, buying an estimated $574 and bringing the position to 1,033 shares worth $223K. The position accounts for 0.02% of the portfolio, ranked #479.
Pinnacle Wealth Planning Services first reported a position in BIIB in Q4 2017 and has held it in 16 quarters since. The position peaked at $434K in Q3 2018. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Pinnacle Wealth Planning Services held 1,033 shares of Biogen worth $223K as of Q2 2026.
- Pinnacle Wealth Planning Services bought 3 Biogen shares in Q2 2026, an estimated $574.
- Biogen made up 0.02% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #479 holding.
- Pinnacle Wealth Planning Services first reported a position in Biogen in Q4 2017 and has held it in 16 quarters since.
- Pinnacle Wealth Planning Services's Biogen position peaked at $434K in Q3 2018.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.